Effect of Platinum-based Versus Non-platinum-based Neoadjuvant Chemotherapy in Triple-negative Breast Cancer

NCT05872412 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

82

Enrollment

OTHER

Sponsor class

Conditions

Triple Negative Breast Cancer

Interventions

DRUG: Doxorubicin
DRUG: Cyclophosphamide
DRUG: Paclitaxel
DRUG: Carboplatin

Sponsor

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh